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MsbA is an essential ABC transporter in Escherichia
coli required for exporting newly synthesized lipids
from the inner to the outer membrane. It remains un-
certain whether or not MsbA catalyzes trans-bilayer
lipid movement (i.e. flip-flop) within the inner mem-
brane. We now show that newly synthesized lipid A ac-
cumulates on the cytoplasmic side of the inner mem-
brane after shifting an E. coli msbA missense mutant to
the non-permissive temperature. This conclusion is
based on the selective inhibition of periplasmic, but not
cytoplasmic, covalent modifications of lipid A that occur
in polymyxin-resistant strains of E. coli. The accessibil-
ity of newly synthesized phosphatidylethanolamine to
membrane impermeable reagents, like 2,4,6-trinitroben-
zene sulfonic acid, is also reduced severalfold. Our data
showed that MsbA facilitates the rapid translocation of
some lipids from the cytoplasmic to the periplasmic side
of the inner membrane in living cells.
The envelope of Gram-negative bacteria contains two dis-
tinct lipid bilayers. The inner membrane lipids consist largely
of phosphatidylethanolamine (PE),1 phosphatidylglycerol, and
cardiolipin (1–3). The outer membrane is an asymmetric bi-
layer with glycerophospholipids on its inner surface and the
lipid A moiety of lipopolysaccharide (LPS) on the outside (1–3).
Lipid A biosynthesis is required for the growth of Escherichia
coli and other Gram-negative bacteria (1). It is an excellent
target for novel antibiotics (4, 5). Lipid A is also a very potent
stimulant of the human innate immune system via Toll-like
receptor 4 (6, 7).
The constitutive enzymes of phospholipid and lipid A biosyn-
thesis are well characterized in E. coli (1, 3, 8, 9). They are
localized in the cytoplasm or on the cytoplasmic side of the inner
membrane. It remains unclear how newly synthesized lipids are
moved across the inner membrane and are exported to the outer
membrane (1, 10, 11). Trans-bilayer phospholipid movement is
kinetically unfavorable in model systems and therefore is
thought to be protein-mediated in biological membranes (12–16).
The transport of newly synthesized phospholipids and LPS
from the inner to the outer membrane of E. coli is dependent
upon the ABC transporter MsbA (10, 17). This protein is es-
sential for E. coli growth and is highly conserved in Gram-
negative bacteria (18). It is closely related to the mammalian
P-glycoproteins, especially those that confer multidrug resist-
ance (18–20). X-ray structures of MsbA are available (20, 21)
and support the view that MsbA might function as a lipid
flippase. We previously isolated a temperature-sensitive msbA
mutant, in which newly synthesized phospholipids and LPS
accumulate in the inner membrane under non-permissive con-
ditions (10). Our work demonstrated a critical role for MsbA in
lipid export (10, 17) but left unanswered the question whether
or not MsbA is an inner membrane lipid flippase.
There is considerable disagreement in the literature concern-
ing the mechanism of trans-bilayer lipid movement. In some
biological membranes, lipid flip-flop appears to be ATP-inde-
pendent, arguing against the involvement of an ABC trans-
porter (22–24). Kol et al. (15, 24) have shown that lipid flip-flop
in phospholipid vesicles is stimulated by almost any mem-
brane-spanning helical peptide. Hrafnsdottir et al. (14) have
reported ATP-independent flippase activity in Gram-positive
membrane vesicles but have not isolated a transport protein or
established a mechanism. On the other hand, Margolles et al.
(25) have demonstrated ATP-dependent lipid flippase activity
associated with the LmrA protein, an MsbA homologue from
the Gram-positive bacterium Lactococcus lactis, which confers
resistance to a variety of amphiphilic drugs. The ATPase ac-
tivity that is associated with purified MsbA is greatly stimu-
lated by lipids (26), especially by Kdo2-lipid A, but reconstitu-
tion of ATP-dependent lipid flip-flop with pure MsbA in
phospholipid vesicles has not been successful (27).
Most studies of in vitro lipid flip-flop have employed short
chain or relatively hydrophilic lipid analogues, modified with
chromophores, spin labels, or radioactive moieties to measure
transport (14, 24, 28, 29). Because in vitro flip-flop assays may
not accurately reflect what is taking place inside E. coli, we
have examined MsbA function in living cells. Upon inactivation
of MsbA in the msbA2 temperature-sensitive mutant WD2 (10),
newly made LPS, and possibly PE, accumulate preferentially
on the inner face of the inner membrane as judged by the
accessibility to enzymatic modification and labeling with mem-
brane-impermeable reagents. These results provided the first
direct evidence that rapid movement of some lipids across the
inner membrane of E. coli is dependent upon MsbA.
EXPERIMENTAL PROCEDURES
Materials—Tryptone and yeast extract were from Difco. Radioiso-
topes were purchased from PerkinElmer Life Sciences. Protein concen-
trations were determined with the BCA protein assay reagent from
Pierce using bovine serum albumin as the standard (30). Sulfo-N-
hydroxysuccinimidobiotin (sulfo-NHS)-biotin was purchased from
Pierce, and 2,4,6-trinitrobenzene sulfonic acid (TNBS) was from Sigma.
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All other chemicals were reagent-grade and purchased from either
Sigma or Mallinckrodt.
Strain Construction—Strain WD2 bearing the temperature-sensitive
msbA2 mutation has been described previously (10) (see Table I). It is
derived from strain W3110 (E. coli Genetic Stock Center). A P1vir lysate
of the polymyxin resistant E. coli mutant WD101 (31, 32), harboring a
mutation (designated pmrAC) that constitutively activates the PmrA
transcription factor, was used to transduce WD2 to polymyxin resist-
ance. P1vir transduction was carried out as described (33, 34), except
that the transduced cells were allowed to grow overnight in the absence
of polymyxin to express the resistance phenotype prior to selection with
polymyxin (10 g/ml in LB plates). A polymyxin-resistant colony was
repurified and tested for temperature-sensitive growth. The desired
strain was designated WD201. A marked derivative of the wild-type
E. coli K12 strain W3110, designated W3110A (aroA::Tn10), was pre-
pared by P1vir transduction using the same aroA::Tn10 donor strain as
was used to generate WD2 (see Table I).
The Salmonella lpxO gene on plasmid pHSG1 (35) was introduced
into both W3110 and WD2 by electroporation. The transformants were
selected based on their resistance to ampicillin. LpxO is an inner
membrane hydroxylase (35, 36) that converts the secondary myristate
chain at the lipid A 3-position to S-2-hydroxymyristate in a reaction
that requires molecular oxygen, iron, ascorbate, and -ketoglutarate.
Cell Labeling and Isopyknic Sucrose Gradient Centrifugation—
Strains WD101 and WD201 were grown at 30 °C, shifted to 44 °C for 30
min, and labeled for 10 min with 32Pi (1 Ci/ml, 9000 Ci/mmol), as
described previously (10). Inner and outer membranes were separated
by sucrose gradient ultracentrifugation (17). Fractions from the sucrose
gradient were subjected to mild acid hydrolysis at pH 4.5 in the pres-
ence of SDS to release the lipid A from the LPS core sugars prior to lipid
A and phospholipid extraction with chloroform/methanol (10, 17). La-
beled lipids were resolved by thin layer chromatography (TLC) in the
solvent system chloroform, pyridine, 88% formic acid, H2O (50:50:16:5,
v/v), and radioactive phospholipids were visualized and quantified on
the plate using a PhosphorImager equipped with IQMac software. The
marker enzymes phospholipase A (outer membrane) and NADH oxi-
dase (inner membrane) were measured (17) and expressed as the per-
cent of the total activity/fraction across the gradient. Total protein was
measured with the BCA assay (30). The radioactivity of each fraction
was determined using a liquid scintillation counter.
Sulfo-NHS-biotin and TNBS Modification of Newly Synthesized
PE—Overnight cultures of W3110A and mutant WD2 cells were diluted
1:100 into LB broth, pH 7.0. Cells were grown with shaking at 30 °C
until a cell density (A600) of 0.5–1.0 was reached. Cells were then diluted
1:4 into 10 ml of LB broth, pre-warmed to 44 °C, and grown with
shaking for another 30 min. Next, 1 Ci/ml 32Pi was added, and the cells
were grown for an additional 10 min. Flasks were cooled on ice, and the
cells were collected by centrifugation for 10 min at 4000  g at 2 °C.
For sulfo-NHS-biotin modification of PE, the cells were washed twice
with ice-cold 10 mM Tris chloride, pH 8.6, containing 140 mM NaCl. The
washed pellet was then resuspended in 4 ml of the same buffer at 0 °C.
Sulfo-NHS-biotin was added at a final concentration of 0–2 mg/ml, as
indicated, and the cells were incubated on ice for 0–4 h. Reactions were
quenched by the addition of 50 mM glycine, and the cells were collected
in a microcentrifuge.
For the TNBS modification of PE, the cell pellet was washed twice
with ice-cold phosphate-buffered saline. The washed pellet was resus-
pended in 10 ml of cold 50 mM NaHCO3, pH 8.5, containing 100 mM
NaCl. The TNBS was added to give a final concentration of 3 mM by
dilution from a fresh 5% commercial stock solution (Sigma) in water,
and the cells were incubated on ice. The reaction was stopped at indi-
cated times by addition of 50 l of 5% bovine serum albumin and 200 l
of 30% trichloroacetic acid/ml of cells. The cells were collected using a
microcentrifuge. For the separation of TNBS-modified membranes by
isopyknic sucrose density gradient ultracentrifugation, 32Pi-labeled
cells were incubated in the presence of 3 mM TNBS on ice for 90 min.
The reaction was stopped by the addition of an equal volume of 20 mM
Tris chloride, pH 8.0, in 1% bovine serum albumin without trichloro-
acetic acid, and the membranes were prepared (10, 17) and separated
into inner and outer fractions.
Glycerophospholipids present in cell pellets or sucrose density gra-
dient fractions were extracted using a single phase Bligh-Dyer mixture
consisting of chloroform:methanol:H2O (1:2:0.8, v/v) but without the
prior mild acid treatment described above, which is used to release lipid
A from LPS. Insoluble material was removed by centrifugation for 5
min at 20,000  g in a microcentrifuge, and the supernatant was
removed and converted to a two phase system by the addition of chlo-
roform and water (final chloroform:methanol:H2O ratio of 2:2:1.8, v/v).
Following a brief centrifugation to separate the phases, the upper phase
was removed and discarded, and the lower phase was washed with a
fresh pre-equilibrated upper phase. The lower phase was dried, redis-
solved in a small volume of chloroform:methanol (4:1, v/v), and spotted
onto a Silica Gel 60 TLC (Merck). Sulfo-NHS-biotin-modified lipids
were resolved in chloroform:methanol:acetic acid:H2O (25:15:4:2, v/v),
and TNBS-modified lipids were resolved in chloroform:methanol:H2O
(65:25:4, v/v). Radioactive phospholipids were detected using a Phos-
phorImager and quantified using IQMac software.
RESULTS
Lipid A Modification with Phosphoethanolamine and Ami-
noarabinose Requires MsbA—Earlier studies of the tempera-
ture-sensitive MsbA mutant WD2 demonstrated the accumu-
lation of newly synthesized phospholipids and lipid A in the
inner membrane following inactivation of MsbA at 44 °C (10).
These findings are consistent with two alternative mecha-
nisms. In one scenario, MsbA catalyzes the trans-bilayer move-
ment of newly synthesized lipids (Fig. 1A, the “flip-flop” model).
In this case, newly synthesized lipids would accumulate on the
inner face of the inner membrane upon inactivation of MsbA.
Alternatively, MsbA could catalyze the ejection of lipids from
the outer face of the inner membrane. In the latter case, lipid
flip-flop could occur by a different (as yet unknown) mecha-
nism, and it might be MsbA-independent (Fig. 1B, the “ejec-
tion” model). The second scenario is similar to the proposed
mechanism of action for the lipoprotein transporter LolCDE
(37).
Polymyxin-resistant mutants of E. coli, such as WD101, har-
bor a mutation (designated pmrAC) that constitutively acti-
vates the PmrA transcription factor (31, 32). PmrA is required
for the production of several enzymes needed for the synthesis
and attachment of aminoarabinose and phosphoethanolamine
FIG. 1. Possible functions of MsbA in the export of newly syn-
thesized lipids in E. coli. A, in the “flip-flop” model, MsbA catalyzes
the ATP-dependent trans-bilayer movement of newly synthesized core-
lipid A and glycerophospholipids within the inner membrane. In this
case, newly made lipids would accumulate at the cytoplasmic face of the
inner membrane upon loss of MsbA function. B, in the “ejection” model,
MsbA catalyzes the ATP-dependent movement of newly made lipids
from the outer surface of the inner membrane into the periplasm and/or
outer membrane. In this case, newly made lipids would accumulate on
the periplasmic surface of the inner membrane following MsbA
inactivation.
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groups to lipid A (Fig. 2, blue substituents). These amine-
containing substituents reduce the net negative charge of the
cell surface and decrease its affinity for cationic anti-microbial
peptides, including polymyxin (31, 32). As explained in the
legend to Fig. 2, the addition of aminoarabinose and phospho-
ethanolamine groups are catalyzed by distinct enzymes (ArnT
and EptA/PmrC, respectively),2 which face the periplasmic sur-
face of the inner membrane (31, 32, 38, 39). These modifica-
tions should require the flip-flop of lipid A from the cytoplasmic
to the periplasmic surface of the inner membrane and therefore
are markers for the trans-membrane movement of newly syn-
thesized lipid A.
To examine the accessibility of newly made lipid A to ArnT
and EptA/PmrC, we constructed strain WD201, which carries
the temperature-sensitive msbA allele of WD2 together with
the polymyxin resistance gene (pmrAC) of WD101 (Table I).
WD101 and WD201 were pulse-labeled for 10 min with 32Pi
following 30 min of growth at 44 °C to inactivate MsbA in
WD201. Cells were harvested, and inner and outer membranes
were separated by isopyknic sucrose gradient ultracentrifuga-
tion. Glycerophospholipids and lipid A molecules present in
each fraction were extracted, separated by TLC, and visualized
using a PhosphorImager.
As shown in Fig. 3, A and B, sucrose gradient ultracentrifu-
gation efficiently separated the outer and inner membranes of
both strains as judged by marker enzyme assays. As seen in
Fig. 3, C and E, the analysis of fractions from the polymyxin-
resistant strain WD101(pmrAC) revealed that glycerophospho-
lipids are evenly distributed between the outer and inner mem-
branes, similar to what is seen in wild-type cells, like the
parental strain W3110 (10). Lipid A from the latter strain
migrates just below PE in this system (10). However, the lipid
A molecules from the polymyxin-resistant strain WD101 are
displayed as a group of slowly migrating bands (Fig. 3E, left
arrows 1–4). This pattern is because of the presence of one or
two hydrophilic phosphoethanolamine and/or aminoarabinose
2 PmrC is an older designation for the enzyme EptA and should not be
confused with the constitutively active version of the transcription
factor, PmrAC.
FIG. 2. Enzymatic modification of lipid A on the periplasmic or cytoplasmic surfaces of the inner membrane. Both EptA/PmrC (38,
39)2 and ArnT (31, 32) are polytopic membrane proteins, which are induced in polymyxin-resistant pmrAc mutants, such as WD101. These proteins
have large domains that face the periplasm. Given that the donor substrate for ArnT is undecaprenyl-phosphate-L-4-aminoarabinose (31, 32), the
active site of ArnT must face the periplasmic side of the inner membrane. EptA/PmrC utilizes PE as its phosphoethanolamine donor (38), and it
contains a large, catalytic C-terminal domain that has been shown to face the periplasm, as judged by the analysis of PhoA fusions (39). LpxO has
only two transmembrane domains (one at the N terminus and one near the C terminus) with a large, central active site region that faces the
cytoplasm (35). LpxO requires Fe2, ascorbate, and -ketoglutarate as co-substrates, which are present in the cytoplasm (35).
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groups (31, 32, 40), as explained in the legend. These modified
lipid A species are present mainly in the outer membrane when
MsbA is functional (Fig. 3E).
Fig. 3, D and F show the analysis of the sucrose gradient
fractions from the polymyxin-resistant strain WD201, which in
addition to pmrAC contains the temperature-sensitive msbA2
mutation. WD201 accumulates newly made phospholipids and
lipid A within its inner membrane after a shift to 44 °C (Fig. 3,
D and F), similar to what is seen in the polymyxin-sensitive
parental strain WD2 (10). However, the lipid A that accumu-
lates in the inner membrane of WD201 is largely unmodified,
as judged by its migration just below PE (Fig. 3F, right arrow).
These data indicate that following the inactivation of MsbA
newly made lipid A does not gain access to ArnT and EptA/
PmrC (Fig. 2), supporting the view that MsbA plays a critical
role in the trans-bilayer movement of lipid A.
Hydroxylation of Newly Made Lipid A by LpxO Is MsbA-
independent—To make certain that newly synthesized lipid A
is not sequestered from all enzymes involved in lipid A modi-
fication when msbA is inactivated, we constructed a derivative
of WD2 and its parent W3110 expressing the Salmonella lpxO
gene (Fig. 2), an inner membrane hydroxylase that can func-
tion only when the biosynthesis of hexa-acylated lipid A is
completed (35). The active site of LpxO must face the cytoplasm
given that it utilizes several cytoplasmic substrates (Fig. 2).
Inactivation of the MsbA mutant protein in WD2/pHSG1 did
not interfere with lipid A hydroxylation when compared with
W3110/pHSG1 (Fig. 4), consistent with the unrestricted acces-
TABLE I
Strains and plasmids used in this study
Strains Relevant genotype and description Source
E. coli
W3110 Wild type, F,  CGSCa
LCB273 F aroA::Tn10 CGSC
W3110A aroA::Tn10 msbA (TetR P1vir transductant of W3110; LCB273 donor) This work
WD2 aroA::Tn10 msbA2 (TetR ts P1vir transductant of W3110; mutagen-treated LCB273 donor) Doerrler, Reedy, Raetz (10)
WD101 pmrAC (polymyxin-resistant mutant of W3110) Trent, Ribeiro, et al. (32)
WD201 aroA::Tn10 msbA2 pmrAC (polymyxin-resistant P1vir transductant of WD2; WD101 donor) This work
Plasmid
pHSG1 pBluescriptSK expressing Salmonella typhimurium lpxO Gibbons, et al. (35)
a CGSC, E. coli Genetic Stock Center, Yale University, New Haven, CT.
FIG. 3. Modification of lipid A with
aminoarabinose and phosphoethano-
lamine groups is MsbA-dependent.
Membranes were separated into inner
and outer fractions using isopycnic su-
crose gradient centrifugation. Outer and
inner membrane marker enzymes, phos-
pholipase A (red ) and NADH oxidase
(blue squares), respectively, and total pro-
tein concentration (black circles) were
measured in each fraction and calculated
as percent of the total. Radioactivity (32P)
in each fraction was determined by sam-
pling 50 l. Radioactive lipids separated
by TLC plates were detected using a
PhosphorImager. Positions of modified
(left arrows 1–4) or unmodified (right ar-
row) lipid A species are indicated. In pre-
vious studies, we identified 1 as a lipid A
modified with a single aminoarabinose
group, 2 with a single phosphoethano-
lamine, 3 with an aminoarabinose and a
phosphoethanolamine group, and 4 with
two phosphoethanolamine groups (31,
32).3 A, C, and E, WD101 (pmrAC); B, D,
and F, WD201 (pmrACmsbA2). The
strains were grown at 30 °C to A600  1.0,
diluted 4-fold into LB broth, equilibrated
at 44 °C, and grown for an additional 30
min to inactivate MsbA. Next, 32Pi was
added to a final concentration of 4 Ci/ml,
and growth was continued for 10 min to
label newly synthesized phospholipids
and lipid A. PG, phosphatidylglycerol.
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sibility of newly made lipid A to LpxO on the inner surface of
the inner membrane under conditions that block lipid export
and lipid A modification with phosphoethanolamine or amino-
arabinose (Fig. 4). As an additional control the concurrent
formation of the lipid A diphosphate variant (Fig. 4A), which
was previously shown to be MsbA-dependent (17), was deter-
mined in this construct. As shown in Fig. 4B, formation of the
lipid A diphosphate variant during the 10-min labeling with
32Pi following MsbA inactivation in WD2/pHSG1 is reduced by
more than 85%.
Reduced Accessibility of Newly Synthesized PE to Membrane-
impermeable Reagents following MsbA Inactivation—We next
asked the question of whether or not newly synthesized PE, the
major glycerophospholipid of E. coli, accumulates on the inner
or outer face of the inner membrane following inactivation of
MsbA in WD2. To address this question, we first utilized the
cell-impermeable, amine-reactive reagent, sulfo-NHS-biotin
(41). W3110A and WD2 cells were grown for 30 min at 44 °C,
labeled for 10 min with 32Pi, and then incubated on ice in the
presence of 0, 1, or 2 mg/ml of sulfo-NHS-biotin. Portions were
removed at different times, and the reactions were quenched by
the addition of excess glycine. Phospholipids were extracted,
separated by TLC, and quantified with a PhosphorImager. Fig.
5A shows a time course of biotinylation of the 32P-labeled PE in
the parental strain W3110A. Covalent modification of the
newly synthesized PE with sulfo-NHS-biotin is very efficient.
Up to 25% of the total cellular PE is modified. The migration of
the biotinyl-PE in this TLC system was confirmed by biotinyl-
ation of a commercial PE standard (data not shown).
PE biotinylation in W3110A was compared with that in WD2
following MsbA inactivation by growth at 44 °C for 30 min. The
biotinylation of newly synthesized PE was much less efficient
in WD2 than in W3110A (Fig. 5, B versus A). When quantified
by PhosphorImager analysis, the extent of newly synthesized
PE modification was reduced 2–3-fold in WD2 compared with
W3110A (Fig. 5C). Some of the modified PE seen in WD2 (Fig.
5) might be attributed to the leakiness of the msbA2 point
mutation or by other processes facilitating PE flip-flop at a
slower rate. It could also be caused by a limited penetration of
sulfo-NHS-biotin into the cytoplasmic compartment during the
prolonged incubation of the cells with the reagent (Fig. 5).
The relative inaccessibility of newly synthesized PE to chem-
ical modification in WD2 was confirmed using TNBS, a differ-
ent reagent that has been used to label free amine groups of
lipids in many classical studies of membrane topography (13,
42, 43). W3110A and WD2 cells were grown for 30 min at 44 °C,
labeled with 32Pi for 10 min, and then incubated on ice in the
presence of 0 or 3 mM TNBS. Portions were removed at differ-
ent times, and the reaction was quenched by the addition of
Tris buffer, albumin, and trichloroacetic acid. Phospholipids
were extracted, separated by TLC, and quantified. As shown in
Fig. 6A, newly synthesized PE in W3110A is efficiently modi-
fied under these conditions. 30% of the 32P-labeled PE is
converted to [32P]trinitrophenyl(TNP)-PE after 90 min of incu-
bation with 3 mM TNBS (Fig. 6C). In contrast, newly synthe-
sized PE in WD2 cells is much less susceptible to modification
by TNBS (Fig. 6, B and C). Only 10–12% of the newly synthe-
FIG. 4. LpxO-catalyzed hydroxylation of newly synthesized
lipid A is MsbA-independent. E. coli W3110 (msbA) or WD2
(msbA2), both harboring lpxO on pHSG1, were grown at 30 °C to A600 
0.5 and then back-diluted 1:3 into fresh pre-warmed LB medium at
44 °C, or fresh LB medium at 30 °C. Cells were grown for another 30
min and then labeled for 10 min with 3 Ci/ml 32Pi. Cells were collected
by centrifugation. The labeled lipid A was recovered following hydrol-
ysis of the cell residue at pH 4.5, as described (17, 58). The 32P-labeled
lipid A species were resolved by TLC into four major components (A).
The ratio of 2-hydroxylated lipid A (X  OH) to total lipid A (X  H or
OH) was determined by PhosphorImager analysis (B). The same TLC
data was used to calculate the percent of lipid A molecules bearing the
diphosphate substituent (17, 58). Like phosphoethanolamine and ami-
noarabinose modification, formation of the diphosphate is MsbA-de-
pendent (17) and serves as an internal control for the MsbA independ-
ent 2-hydroxylation reaction. ts, temperature-sensitive.
FIG. 5. Reduced modification of newly made PE with sulfo-
NHS-biotin following inactivation of MsbA. W3110A (aroA::Tn10)
and WD2 (aroA::Tn10 msbA2) growing exponentially at 30 °C were
shifted to 44 °C for 30 min and then labeled with 32Pi for 10 min.
Washed cells were treated with 0, 1, or 2 mg/ml NHS-biotin on ice for 1,
2, or 4 h, as indicated. Reactions were quenched with 50 mM glycine.
Phospholipids were extracted and separated by TLC using the solvent
chloroform:methanol:acetic acid:H2O (25:15:4:2, v/v). A and B, PE and
biotin-modified PE are indicated with arrows. C, the percent conversion
of PE to biotinyl-PE with time was calculated at 2 mg/ml
sulfo-NHS-biotin.
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sized PE in WD2 is derivatized under the same incubation
conditions. These findings are consistent with the sulfo-NHS-
biotin experiment (Fig. 5). Taken together, these data support
a role for MsbA in facilitating the rapid trans-bilayer move-
ment of both PE and lipid A in E. coli.
Modification of Newly Synthesized PE Reaching the Outer
Membrane in WD2 Is Unaffected by Inactivation of MsbA—If
MsbA is required mainly for the translocation of newly synthe-
sized PE across the inner membrane, one would predict that
any PE exported to the outer membrane in WD2 at 44 °C due to
leakiness of the msbA2 mutation would be as susceptible to
TNBS modification as in wild-type cells. Accordingly, W3110A
and WD2 cells were grown for 30 min at 44 °C, labeled with
32Pi, and treated with 3 mM TNBS on ice for 90 min. The
reactions were quenched, as described above, with Tris buffer
and albumin but without trichloroacetic acid. Membranes were
prepared and separated into inner and outer fractions by isopyk-
nic sucrose gradient ultracentrifugation. Phospholipids were
extracted as in Fig. 6. Although inner and outer membranes
were resolved from each other in both W3110A and WD2, as
judged by marker enzyme analysis (Fig. 7, A and B), most of the
newly synthesized phospholipids remained associated within
the inner membrane in mutant WD2, whereas the lipid radio-
activity in W3110A was equally distributed (Fig. 7, D and C,
respectively). The amount of TNP-PE present in each fraction
was quantified (Fig. 7, E and F) and expressed as the percent-
age of the total PE in that fraction (Fig. 7, G and H). In strain
W3110A, TNBS-modified PE is 20% of the total or higher in all
of the fractions. In WD2, the percentage of TNBS-modified PE
is approximately the same as wild-type in the outer membrane
fractions (Fig. 7H). However, the peak inner membranes of
WD2 contained 3–5-fold less modified PE than did those of
W3110A. The results indicated that some of the modified PE
seen in WD2 (Figs. 5 and 6) originates from newly synthesized
PE that reached the outer membrane, most likely because of
the leakiness of the msbA2 point mutation. Newly synthesized
inner membrane PE in WD2 is much less accessible to TNBS
than in the wild-type suggesting a predominant cytoplasmic
orientation of this lipid.
DISCUSSION
The inactivation of MsbA in WD2, or in related strains har-
boring the msbA2 mutation, leads to rapid accumulation of
newly synthesized core-lipid A and glycerophospholipid mole-
cules within the inner membrane (Figs. 3 and 7) (10). We have
now demonstrated that the modification of newly synthesized
lipid A with phosphoethanolamine and aminoarabinose groups
in polymyxin-resistant mutants (31, 32) is also MsbA-depend-
FIG. 6. Reduced modification of newly made PE with TNBS
following inactivation of MsbA. W3110A (aroA::Tn10) and WD2
(aroA::Tn10 msbA2) growing exponentially at 30 °C were shifted to
44 °C for 30 min and then labeled with 32Pi for 10 min. Washed cells in
ice-cold phosphate-buffered saline were treated with 3 mM TNBS on ice
for the indicated times. Reactions were quenched with albumin and
trichloroacetic acid. The phospholipids were extracted and separated by
TLC using the solvent chloroform:methanol:H2O (65:25:4, v/v). A and B,
PE and TNP-PE are indicated with arrows. C, the percent conversion of
PE to TNP-PE with time was calculated.
FIG. 7. TNBS modification of newly made PE reaching the
outer membrane in WD2 is unaffected by inactivation of MsbA.
W3110A (aroA::Tn10) and WD2 (aroA::Tn10 msbA2) growing exponen-
tially at 30 °C were shifted to 44 °C for 30 min and then labeled with
32Pi for 10 min. Washed cells in ice-cold phosphate-buffered saline were
treated with fresh 3 mM TNBS on ice for 90 min. The reaction was
quenched with Tris buffer and albumin but without trichloroacetic acid.
The membranes were separated by isopycnic sucrose gradient centrif-
ugation. A and B, outer and inner membrane marker enzymes, phos-
pholipase A (red x), and NADH oxidase (blue squares), respectively, and
protein (black circles) are expressed as the percent of the total, as
described in the legend to Fig. 3. C and D, radioactivity (32P) in each
fraction was determined by counting 50-l samples. E and F, the
radioactive phospholipids were extracted and separated by TLC using
the solvent chloroform:methanol:H2O (65:25:4, v/v). PE, TNP-PE, and
phosphatidylglycerol (PG) are indicated. G and H, the percent of the
total PE in each sucrose gradient fraction that was converted to
TNP-PE was calculated for E and F.
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ent (Fig. 3). However, LpxO-catalyzed hydroxylation of lipid A
(35) is MsbA-independent (Fig. 4). Given the orientation of
these inner membrane enzymes (Fig. 2), we concluded that
MsbA must participate in the flipping of newly synthesized
core-lipid A molecules from the cytoplasmic to the periplasmic
surface of the inner membrane (Fig. 1A). The case is especially
compelling for EptA/PmrC (Fig. 2), because a large pool of PE
is always present on the outer surface of the inner membrane
to serve as a phosphoethanolamine donor substrate for the
modification of a newly synthesized lipid A (23). Recent data
with PhoA fusions of EptA/PmrC have established conclusively
the periplasmic localization of the large conserved C-terminal
domain of this enzyme, which contains the active site (39).
The possibility that MsbA carries out additional functions on
the periplasmic side of the inner membrane must be consid-
ered. ATP hydrolysis might be required for periplasmic lipid
release from MsbA, or for lipid ejection from the outer surface
of the inner membrane in coordination with other envelope
proteins (Fig. 1). Whatever the case may be, the fact that MsbA
was originally identified as a multicopy suppressor of E. coli
LpxL(HtrB) mutants (18, 44, 45), which accumulate tetra-acy-
lated lipid A precursors in their inner membranes unless MsbA
is overproduced (17) supports a direct role for MsbA in
LPS export.
The reduced reactivity of newly synthesized PE toward sulfo-
NHS-biotin (Fig. 5) and TNBS (Fig. 6) following MsbA inacti-
vation in WD2 is intriguing, as it suggests a significant func-
tion for MsbA in catalyzing the trans-bilayer movement of
glycerophospholipids (Fig. 1A). We cannot, however, exclude
the possibility that the accumulation of core-lipid A on the
inner surface of the inner membrane interferes with glycero-
phospholipid flip-flop catalyzed by some other protein. E. coli
mutants with a reduced accessibility of newly synthesized PE
to TNBS modification have not been described previously.
The x-ray structures of E. coli (20) and Vibrio cholera (20, 21)
MsbA strongly suggest that MsbA is a homodimer. This finding
is consistent with the fact that MsbA is closely similar to both
halves of the classical Mdr proteins, the primary sequences of
which are internally duplicated (19). The available x-ray struc-
tures of MsbA (20, 21) are in accord with its proposed function
as a lipid flippase and suggest that the protein can exist in an
open or a closed conformation. The physiological relevance of
these conformations remains controversial (46), but they could
represent different states of MsbA during the transport cycle.
The available MsbA structures are not of the highest possible
resolution. It would be informative to obtain higher-quality
structures of MsbA with bound glycerophospholipid or lipid
A molecules.
Purified MsbA is a phospholipid-activated ATPase (26).
Kdo2-lipid A is an especially potent stimulator of this activity.
Recent attempts to reconstitute ATP-dependent phospholipid
flip-flop in vitro with purified MsbA using fluorescent PE an-
alogues as probes have not been successful (27). These negative
findings do not undermine the conclusions of our genetic stud-
ies. The conditions described by Kol et al. (24, 27) to measure
the PE flip-flop in model liposomes may not accurately reflect
the situation inside of living bacteria. Kol et al. (27) did not
examine the flip-flop of Kdo2-lipid A, which may be the true
substrate for MsbA. Furthermore, additional proteins may be
required for lipid flipping and transport in vivo, because MsbA
might be part of a multiprotein complex. In the case of E. coli
hemolysin, which requires an ABC transporter closely related
to MsbA, an accessory periplasmic protein and an outer mem-
brane protein (TolC) are also needed for secretion (47, 48).
Recent procaryotic genome sequencing strongly supports the
view that other proteins may interact with MsbA in a specific
manner. In some bacteria recovered from the Sargasso Sea (49)
(see GenBankTM accession EAJ39096), the C terminus of MsbA
is fused to LpxK (50, 51), a membrane enzyme that incorpo-
rates the 4-phosphate residue of lipid A (Fig. 2). LpxK is a
separate protein in E. coli, but lpxK is in an operon immedi-
ately downstream of msbA (50, 51). Like MsbA (17), LpxK is
essential for growth (51), but point mutations in lpxK have not
been characterized. A possible role for LpxK in lipid transloca-
tion might be established by searching for temperature-sensi-
tive lpxK alleles that block lipid export without compromising
4-kinase activity. A more general search for additional E. coli
mutants defective in lipid export, based on selectable pheno-
types of WD2, might also prove informative.
A large number of MsbA homologues are present in eucary-
otic organisms (19, 52). Some of these proteins have been re-
ported to catalyze phospholipid flip-flop when reconstituted in
vitro (53). Unlike what is seen with E. coli MsbA, however, no
single eucaryotic ABC transporter has emerged as being essen-
tial for generalized lipid transport (52). The best characterized
eucaryotic ABC transport proteins are implicated in the traf-
ficking of specific lipids. For instance, ABCA1 is required for
reverse cholesterol transport (54, 55), whereas mouse Mdr2 is
needed specifically for biliary phosphatidylcholine secretion
(56, 57). The presence of so many MsbA homologues in euca-
ryotic cells suggests that there may be redundancy of function.
Mutations in multiple selected ABC transporters may be re-
quired to cause generalized lipid transport defects, such as
those associated with the msbA2 mutation in WD2.
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